Vitality Watch

Dossier clinicaltrials trial early 29-jun-2026
Small or early-phase human trial or pilot study

The Wandering Nerve: Gateway to Boost Alzheimer’s Disease Related Cognitive Performance

Key claim: Investigators are testing whether non-invasive RAVANS (tVNS) electrical stimulation can improve cognition in older individuals and whether individual factors modify that effect.

Abstract

In this research study the investigators want to find out if a non-invasive electrical brain stimulation method called RAVANS (also called tVNS) can have a beneficial effect on cognition in older individuals. The investigators also want to understand whether certain individual factors contribute to the effect of RAVANS on cognition. RAVANS is only used in research studies.

Why this matters

Investigators are testing whether non-invasive RAVANS (tVNS) electrical stimulation can improve cognition in older individuals and whether individual factors modify that effect.

Source

Link

Briefing card

The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive Performance
Stage: trial early · clinicaltrials · 29-jun-2026

Investigators are testing whether non-invasive RAVANS (tVNS) electrical stimulation can improve cognition in older individuals and whether individual factors modify that effect.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT04908358

build build 880 · 2bcef25 · 2026-11-18